- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Fingertip.
Displaying page 1 of 1.
EudraCT Number: 2015-001788-37 | Sponsor Protocol Number: HCA-2015-2 | Start Date*: 2015-06-29 | ||||||||||||||||
Sponsor Name:Heart Center Co. Tampere University Hospital | ||||||||||||||||||
Full Title: Effects of volume changes to the plethysmography signal on major surgery patients | ||||||||||||||||||
Medical condition: Patients scheduled for elective CABG (Coronary artery bypass surgery). Patients scheduled for elective open major abdominal surgery (gastrointestinal surgery). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002365-21 | Sponsor Protocol Number: BH4-1 | Start Date*: 2004-11-03 |
Sponsor Name:John F. Kennedy Institute | ||
Full Title: Trial with BH4, a new and simple treatment of phenylketonuria, PKU | ||
Medical condition: PKU, phenylketonuria, is a rare, inherited metabolic disease that results in mental retardation if not a very strict low-protein diet is started within the first weeks of life. The conversion of p... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004776-20 | Sponsor Protocol Number: BAP00626 | Start Date*: 2006-03-27 |
Sponsor Name:Basilea Pharmaceutica Ltd | ||
Full Title: Safety and Efficacy of Alitretinoin in the Treatment of Severe Refractory Chronic Hand Dermatitis | ||
Medical condition: Severe Chronic Hand Dermatitis (CHaD) Refractory to Topical Therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001719-65 | Sponsor Protocol Number: CALC-SSc | Start Date*: 2018-12-10 |
Sponsor Name:University Medial Center Groningen | ||
Full Title: CALCification as an early marker of vasculopathy and organ involvement in Systemic Sclerosis CALC-SSc study | ||
Medical condition: Systemic sclerosis (SSc) is a rare progressive autoimmune disease hallmarked by severe vasculopathy. Patients are prone to enhanced calcification of skin and the vasculature. Active calcifications ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000345-38 | Sponsor Protocol Number: BAP00089 | Start Date*: 2004-07-13 |
Sponsor Name:Basilea Pharmaceutica Ltd | ||
Full Title: Efficacy and Safety of BAL4079 in the Treatment of Severe Refractory Chronic Hand Dermatitis | ||
Medical condition: Severe Chronic Hand Dermatitis (CHaD) Refractory to Topical Therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) CZ (Completed) HU (Completed) DK (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000687-33 | Sponsor Protocol Number: HOPE | Start Date*: 2015-11-18 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Randomized placebo-controlled trial to investigate clinical efficacy, anti-inflammatory properties and safety of prednisolone in hand osteoarthritis: a proof-of-concept study | ||
Medical condition: Hand osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013468-37 | Sponsor Protocol Number: Protocol code BA7 | Start Date*: 2010-09-29 | ||||||||||||||||
Sponsor Name:Royal National Hospital for Rheumatic Disease | ||||||||||||||||||
Full Title: A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in the management of Raynaud’s phenomenon. | ||||||||||||||||||
Medical condition: Primary Raynaud's Phenomenon and Systemic Sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003013-96 | Sponsor Protocol Number: AVXCLIN003 | Start Date*: 2016-10-03 | |||||||||||
Sponsor Name:Avexxin AS | |||||||||||||
Full Title: A Randomised, Blinded, Placebo-controlled, Single Centre Pilot Study to evaluate the Safety and Efficacy of AVX001 3% Ointment (NG) administered Topically Once Daily to Patients with mild, moderate... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003450-28 | Sponsor Protocol Number: CL009_282 | Start Date*: 2007-09-04 | |||||||||||
Sponsor Name:ChemoCentryx, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac Disease | |||||||||||||
Medical condition: Celiac Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003579-38 | Sponsor Protocol Number: APIDR_C_02083 | Start Date*: 2007-11-13 | |||||||||||
Sponsor Name:sanofi-aventis groupe | |||||||||||||
Full Title: Effect of insulin glulisine compared to insulin aspart and insulin lispro when administered by Continuous Subcutaneous Insulin Infusion (CSII) on specific pump parameters in patient with Type 1 Dia... | |||||||||||||
Medical condition: Type I Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) SE (Completed) NL (Completed) AT (Completed) HU (Completed) IT (Completed) ES (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016035-35 | Sponsor Protocol Number: NAI113678 | Start Date*: 2009-11-13 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: An Open-Label, Multi-Center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirm... | |||||||||||||
Medical condition: Hospitalized adult, adolescent and pediatric subjects with influenza infection. | |||||||||||||
|
|||||||||||||
Population Age: In utero, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) ES (Completed) DE (Completed) GB (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
